secwatch.observer — SEC 8-K summary
======================================

Issuer:     Pluri Inc. (PLUR)
CIK:        0001158780
Form:       8-K
Filed at:   2024-01-08T23:59:59+00:00
Accession:  0001213900-24-001725
Event type: other_material
Sentiment:  neutral
Materiality: 0.45
Item codes: 8.01
LLM model:  deepseek-v4-flash:cloud@v2

Pluri launches PluriCDMO cell therapy manufacturing division led by Andy Lewin
------------------------------------------------------------------------------

- New CDMO division PluriCDMO offers services from preclinical through commercialization.
- Division will be led by Andy Lewin, an experienced CDMO executive.
- Mission to deliver high-quality essential therapies; no financial guidance provided.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1158780/000121390024001725/0001213900-24-001725-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1158780/000121390024001725/ea191307-8k_pluriinc.htm
  HTML page:      https://secwatch.observer/filing/0001213900-24-001725

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer